Enoxiluv Kit
NDC Package 76420-532-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Enoxiluv Kit (enoxaparin sodium, isopropyl alcohol) kits is enoxaparin sodium injection is contraindicated in patients with:Active major bleeding. This formulation utilizes a kit delivery system. Marketed by Asclemed Usa, Inc., this product is identified by NDC 76420-532.

Identification & Billing

NDC Package Code
76420-532-01
Package Description
1 KIT in 1 CARTON * 10 SYRINGE in 1 CARTON (0781-3246-64) / .4 mL in 1 SYRINGE * 5 mL in 1 POUCH
Product Code
76420-532
11-Digit Billing Format
76420053201
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Enoxiluv Kit
Non-Proprietary Name
Enoxaparin Sodium, Isopropyl Alcohol
Dosage Form
Kit - A packaged collection of related material.
Administration Route
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Usage Information
Enoxaparin sodium injection is contraindicated in patients with:Active major bleeding. History of immune-mediated heparin-induced thrombocytopenia (HIT) within the past 100 days or in the presence of circulating antibodies [see Warnings and Precautions ( 5.4)] . Known hypersensitivity to enoxaparin sodium ( e.g., pruritus, urticaria, anaphylactic/anaphylactoid reactions) [see Adverse Reactions (6.2)] . Known hypersensitivity to heparin or pork products. Known hypersensitivity to benzyl alcohol (which is in only the multiple-dose formulation of enoxaparin sodium injection) [see Warnings and Precautions (5.8)].

Regulatory & Marketing

Labeler Name
Asclemed Usa, Inc.
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
02-08-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76420-532-01 identifies a specific commercial package of 1 kit in 1 carton * 10 syringe in 1 carton (0781-3246-64) / .4 ml in 1 syringe * 5 ml in 1 pouch of Enoxiluv Kit, a human prescription drug labeled by Asclemed Usa, Inc.. This kit is formulated for subcutaneous; topical use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Asclemed Usa, Inc. on February 08, 2023. The current certification is valid through December 31, 2026.

How is this Asclemed Usa, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76420053201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76420-532-01
11-Digit CMS (5-4-2)
76420-0532-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.